|
|
|
|
Vol. 56, Issue 1, 54-67, July 1999
Department of Biochemical Pharmacology, Janssen Research
Foundation, Beerse, Belgium (P.B., M.H.M.B., X.L., J.E.L.); Research
Institute Neurosciences, Vrije Universiteit Amsterdam, the Netherlands
(P.B., J.E.L.); Experimental Genetics Group, Centrum voor
Menselijke Erfelijkheid, Vlaams Interuniversitair Instituut voor
Biotechnologie, Katholieke Universiteit Leuven, Campus Gasthuisberg,
Leuven, Belgium (L.U., L.S., F. Van L.); Department of Pathology,
University of Antwerp, Edegem, Belgium (P.C.); Department of Functional
Genomics, Janssen Research Foundation, Beerse, Belgium (W.H.M.L.L.);
and Department of General In Vivo Pharmacology, Janssen Research
Foundation, Beerse, Belgium (A.A.H.P.M.)
We replaced the coding region of the murine 5-hydroxytryptamine
(5-HT)1B receptor by the human 5-HT1B receptor
using homologous recombination in embryonic stem cells and generated
and characterized homozygous transgenic mice that express only the
human (h) 5-HT1B receptor. The distribution patterns of
h5-HT1B and murine (m) 5-HT1B receptor mRNA and
binding sites in brain sections of transgenic and wild-type mice were
identical as measured by in situ hybridization histochemistry and
radioligand receptor autoradiography. When measured in parallel under
identical conditions, the h5-HT1B receptor expressed in
mouse brain had the same pharmacological characteristics as that in
human brain. Stimulation by 5-HT1B agonists of
[35S]guanosine-5'-O-(3-thio)triphosphate
binding in brain sections demonstrated the functional coupling of the
h5-HT1B receptor to G proteins in mouse brain. In tissue
slices from various brain regions, electrically stimulated
[3H]5-HT release was not modified by 5-HT1B
agonists in tissue from either transgenic and wild-type mice; a
5-HT1B antagonist enhanced electrically stimulated
[3H]5-HT release in wild-type mouse brain, but was
ineffective in the transgenics. The centrally active
5-HT1A/5-HT1B agonist RU24969 induced
hypothermia but did not increase locomotor activity in the transgenic
mice. The ineffectiveness of RU24969 in the transgenic mice could be
due to the lower affinity of the compound for the h5-HT1B
receptor compared with the m5-HT1B receptor. The present study demonstrates a complete replacement of the mouse receptor by its
human receptor homolog and a functional coupling to G proteins. However, modulation of [3H]5-HT release could not be
shown. Furthermore, behavioral effects were not clearly observed, which
may be due to a lack of appropriate tools.